butabarbital decreases outcomes of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Carefully. Coadministration of CYP3A4 inducers may perhaps decrease sufentanil levels and efficacy, potentially precipitating withdrawal syndrome in individuals wh